Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and Pruritus

NCT02238236 · clinicaltrials.gov ↗

COMPLETED

Status

3793

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis, Allergic, Perennial

Interventions

DRUG: Alesion®

Sponsor

Boehringer Ingelheim